ICMR
-
The biopolitics of Covaxin
In a new investigation, STAT has reported fresh problems with Covaxin’s approval process in India, including the phase 2 trial dropping its placebo arm in favour of one preordained to make Covaxin look good and Bharat Biotech – the maker – commencing phase 3 trials based on results from animal studies. I’m also filing the report… Continue reading
About Me
I’m a science editor and writer in India, interested in high-energy and condensed-matter physics, research misconduct, pseudoscience, science’s relationship with society, epic fantasy, open source/access/knowledge systems, H.R. Giger’s art, Goundamani’s comedy, Factorio, and most things that require a lot of time to get the hang of.